Influenza A (NP (H3N2))
Online Inquiry
| CAT# | PPO-H061 |
| Application | T-cell assays, Immune monitoring, Antigen specific T-cell stimulation, T-cell expansion, Cellular immune response |
| Purity | >70% (HPLC-MS) |
| Areas of Interest | Infection, Influenza, Seasonal influenza, Respiratory infection |
| Size | 1 vial containing 15 nmol ( 25μg) per peptide |
SwissProt ID | O91743 |
Format | Freeze dried in amber type glass vial |
NumberOfPeptides | 122 |
Organism | Influenza A |
Specifications | Peptide scan (15mers with 11 aa overlap) |
Protein Length | 498 |
Protein Name | Nucleocapsid protein |
References | 1."Live and Inactivated Influenza Vaccines Induce Similar Humoral Responses, but Only Live Vaccines Induce Diverse T-Cell Responses in Young Children"。 Hoft et al., The Journal of Infectious Disease (2011)
3."Rebound of Residual Plasma Viremia After Initial Decrease Following Addition of Intravenous Immunoglobulin to Effective Antiretroviral Treatment of HIV". Mellberg et al., AIDS Research and Therapy (2011) |
Write a review
Ask a question
My Review for Influenza A (NP (H3N2))
Required fields are marked with *
×
Ask a Question for Influenza A (NP (H3N2))
Required fields are marked with *
×
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
